2085P Buprenorphine use and cancer outcomes
Publication
, Conference
Osazuwa-Peters, N; Abouelella, D; Chen, M; Jiang, R
Published in: Annals of Oncology
October 2023
Duke Scholars
Published In
Annals of Oncology
DOI
ISSN
0923-7534
Publication Date
October 2023
Volume
34
Start / End Page
S1096 / S1097
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Osazuwa-Peters, N., Abouelella, D., Chen, M., & Jiang, R. (2023). 2085P Buprenorphine use and cancer outcomes. In Annals of Oncology (Vol. 34, pp. S1096–S1097). Elsevier BV. https://doi.org/10.1016/j.annonc.2023.09.867
Osazuwa-Peters, N., D. Abouelella, M. Chen, and R. Jiang. “2085P Buprenorphine use and cancer outcomes.” In Annals of Oncology, 34:S1096–97. Elsevier BV, 2023. https://doi.org/10.1016/j.annonc.2023.09.867.
Osazuwa-Peters N, Abouelella D, Chen M, Jiang R. 2085P Buprenorphine use and cancer outcomes. In: Annals of Oncology. Elsevier BV; 2023. p. S1096–7.
Osazuwa-Peters, N., et al. “2085P Buprenorphine use and cancer outcomes.” Annals of Oncology, vol. 34, Elsevier BV, 2023, pp. S1096–97. Crossref, doi:10.1016/j.annonc.2023.09.867.
Osazuwa-Peters N, Abouelella D, Chen M, Jiang R. 2085P Buprenorphine use and cancer outcomes. Annals of Oncology. Elsevier BV; 2023. p. S1096–S1097.
Published In
Annals of Oncology
DOI
ISSN
0923-7534
Publication Date
October 2023
Volume
34
Start / End Page
S1096 / S1097
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis